Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
This article has been cited by
1Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh,Zoltán Szekanecz,Tamás Bíró
Frontiers in Immunology.2017;8()
[DOI]
2Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders
Christopher N Andrews,Shane M Devlin,Bernard Le Foll,Benedikt Fischer,Frances Tse,Martin Storr,Stephen E Congly
Journal of the Canadian Association of Gastroenterology.2019;2(1)37
[DOI]
3Cannabidiol for Viral Diseases: Hype or Hope?
Alex Mabou Tagne,Barbara Pacchetti,Mikael Sodergren,Marco Cosentino,Franca Marino
Cannabis and Cannabinoid Research.2020;5(2)121
[DOI]
4Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
Adeyinka Charles Adejumo,Oluwole Muyiwa Adegbala,Kelechi Lauretta Adejumo,Terence Ndonyi Bukong
Canadian Journal of Gastroenterology and Hepatology.2018;2018(2)1
[DOI]
5Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: A systematic review and meta-analysis
Karn Wijarnpreecha,Panadeekarn Panjawatanan,Patompong Ungprasert
Journal of Evidence-Based Medicine.2018;11(4)272
[DOI]
6The potential of cannabidiol in the COVID-19 pandemic
Giuseppe Esposito,Marcella Pesce,Luisa Seguella,Walter Sanseverino,Jie Lu,Chiara Corpetti,Giovanni Sarnelli
British Journal of Pharmacology.2020;177(21)4967
[DOI]
7Cannabinoids and the Coronavirus
Kevin P. Hill
Cannabis and Cannabinoid Research.2020;5(2)118
[DOI]
8Analysis of natural product regulation of opioid receptors in the treatment of human disease
S. Badal,S. Turfus,R. Rajnarayanan,C. Wilson-Clarke,S.L. Sandiford
Pharmacology & Therapeutics.2018;184(2)51
[DOI]
  Feedback 
  Subscribe